ES8307826A1 - "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales". - Google Patents

"procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".

Info

Publication number
ES8307826A1
ES8307826A1 ES511329A ES511329A ES8307826A1 ES 8307826 A1 ES8307826 A1 ES 8307826A1 ES 511329 A ES511329 A ES 511329A ES 511329 A ES511329 A ES 511329A ES 8307826 A1 ES8307826 A1 ES 8307826A1
Authority
ES
Spain
Prior art keywords
same
dihydroimidazo
thiazole
salts
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511329A
Other languages
English (en)
Other versions
ES511329A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kumiai Chemical Industry Co Ltd
Toyo Jozo KK
Original Assignee
Kumiai Chemical Industry Co Ltd
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumiai Chemical Industry Co Ltd, Toyo Jozo KK filed Critical Kumiai Chemical Industry Co Ltd
Publication of ES511329A0 publication Critical patent/ES511329A0/es
Publication of ES8307826A1 publication Critical patent/ES8307826A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE NUEVOS DERIVADOS IMIDAZOTIAZOLES Y DE SUS SALES. SE HACE REACCIONAR EL COMPUESTO AMIDA (II), CON N,N -ETILENO TIOUREA. SE OBTIENE EL COMPUESTO (I) EN QUE R ES (III), DONDE R<1, R<2 Y R<3 SON IGUALES O DIFERENTES Y CONSTITUYEN UN GRUPO SELECCIONADO ENTRE ATOMOS DE HIDROGENO, CLORO, BROMO, GRUPOS ALQUILO INFERIOR O ALCOXILO INFERIOR. R PUEDE SER UN GRUPO FENILO, ETILO, ETILFENILO, CLOROFENILO, BROMOFENILO, CLOROTOLILO, DICLOROFENILO, TRICLOROFENILO, METOXIFENILO, ETOXI-FENILO, METOXICLOROFENILO, DIMETOXICLOROFENILO O ALFA-NAFTILO.
ES511329A 1981-04-10 1982-04-08 "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales". Expired ES8307826A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56054166A JPS57169490A (en) 1981-04-10 1981-04-10 2,3-disubstituted-5,6-dihydro-imidazo(2,1-b)thiazole, its salt and their preparation

Publications (2)

Publication Number Publication Date
ES511329A0 ES511329A0 (es) 1983-07-01
ES8307826A1 true ES8307826A1 (es) 1983-07-01

Family

ID=12962957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511329A Expired ES8307826A1 (es) 1981-04-10 1982-04-08 "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".

Country Status (10)

Country Link
US (2) US4556669A (es)
JP (1) JPS57169490A (es)
CA (1) CA1175842A (es)
CH (1) CH648319A5 (es)
DE (1) DE3213027A1 (es)
ES (1) ES8307826A1 (es)
FR (1) FR2503713B1 (es)
GB (1) GB2099419B (es)
IT (1) IT1190764B (es)
NL (1) NL8201525A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1271480A (en) * 1985-04-22 1990-07-10 Toyo Jozo Co., Ltd. 5,6-dihydroimidazo[2,1-b]thiazole-2-carboxamide derivatives or salts thereof
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
MX2011011833A (es) 2009-05-06 2012-01-27 Lab Skin Care Inc Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas.
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1095524A (en) * 1976-01-19 1981-02-10 Robert E. Moser Antiinflammatory imidazothiazoles
US4041167A (en) * 1976-01-19 1977-08-09 Diamond Shamrock Corporation Antiinflammatory imidazothiazoles

Also Published As

Publication number Publication date
FR2503713B1 (fr) 1985-07-05
GB2099419A (en) 1982-12-08
FR2503713A1 (fr) 1982-10-15
US4629793A (en) 1986-12-16
JPS57169490A (en) 1982-10-19
IT8220644A0 (it) 1982-04-08
CA1175842A (en) 1984-10-09
DE3213027A1 (de) 1983-01-27
GB2099419B (en) 1985-01-09
CH648319A5 (it) 1985-03-15
ES511329A0 (es) 1983-07-01
NL8201525A (nl) 1982-11-01
US4556669A (en) 1985-12-03
IT1190764B (it) 1988-02-24

Similar Documents

Publication Publication Date Title
ES470134A1 (es) Un procedimiento para la produccion de derivados sustituidosde ciclohexano-1,3-diona
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES8402696A1 (es) Procedimiento para la preparacion de (halogeno) alcohil y -alcoxi-sulfonilureas substituidas con radicales heterociclicos.
ES8307826A1 (es) &#34;procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales&#34;.
ES479668A1 (es) Un procedimiento para la preparacion de nuevas 5-alquil- ciopirimidinas.
IE800449L (en) Pyrazoline derivatives.
ES8705854A1 (es) Un procedimiento para la produccion de derivados de benzoilurea
ES457805A1 (es) Un procedimiento para la preparacion de derivados de tiou- rea.
FI845102L (fi) Imidazo/1,2-c/pyrimidiner.
ES8705440A1 (es) Un procedimiento para la produccion de 2h-imidazo-(1&#39;,2&#39;:1,2)-pirrolo-(3,4-b)-piridinas
ES8106150A1 (es) Procedimiento para preparar 5-(clorofenil)-6h-1,3,4-tiadia- zina-2-aminas
AU539870B2 (en) 2-phenylamino-imidazolines-(2)
JPS6425786A (en) Imidazothiadiazine derivative and production thereof
ES8200887A1 (es) Procedimiento para la preparacion de nuevas 2-(perhi- dro-1,4-diazino)-pirimido(5,4-d)pirimidinas
IE780182L (en) N-9,10-DIHYDROLYSERGYL-m-AMINOBENZOIC ACID AMIDES.
IE56917B1 (en) N-sulphenylated hydantoins,a process for their preparation and their use as microbicides
ES8304973A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
ES476529A1 (es) Procedimiento para la obtencion de derivados de 3-aminopro- poxiarilo.
DE3369324D1 (en) Thiolphosphoric-acid esters, their preparation and use
ES8404150A1 (es) Procedimiento para la preparacion de n-pteridinilureas.
ES8107183A1 (es) Procedimiento para la preparacion de derivados de amida de acido o-sulfamoilglicolico
ES8507562A1 (es) Procedimiento para la obtencion de un derivado de organofosfato
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol